Urist Marshall 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Urist Marshall（CIK 1838139）在 1 家公司共报告 25 笔 SEC Form 4 内部人交易（最近一笔 2026-10-05）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 4,126 | $235,595 |
| 2026-09-30 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 4,126 | $238,813 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 8,252 | $0 |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 9,099 | $508,454 |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 9,098 | $502,028 |
| 2026-05-21 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 13,684 | $721,831 |
| 2026-05-15 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 13,684 | $726,073 |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 18,197 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 19,970 | $0 |
| 2026-02-02 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $821,800 |
| 2026-01-26 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $805,200 |
| 2026-01-20 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $790,400 |
| 2026-01-13 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $815,600 |
| 2026-01-06 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $769,600 |
| 2025-12-29 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $786,400 |
| 2025-12-22 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $767,600 |
| 2025-12-17 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 20,000 | $766,400 |
| 2025-12-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 23,334 | $913,526 |
| 2025-12-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 18,242 | $714,174 |
| 2025-12-03 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 23,333 | $931,687 |
| 2025-12-03 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 卖出 | 18,242 | $727,856 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 4,626 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 160,000 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 2,772 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | EVP, Research & Investments | 买入 | 36,484 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-05